- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00538954
Optimised Recovery With Accelerated Nutrition and GI Enhancement (ORANGE)
November 4, 2010 updated by: University of Edinburgh
A Randomised Controlled Trial of Optimised Surgical Recovery: the Potential Synergy Between Enhanced Gastrointestinal Motility and Oral Nutritional/ Metabolic Support
Factors which delay recovery following uncomplicated abdominal surgery include uncontrolled pain, intolerance of diet and poor mobility.
Enhanced recovery after Surgery (ERAS) programmes are perioperative care pathways that address systematically these issues (i.e.
improved dynamic pain relief, optimised nutritional care and enforced mobilisation) to promote a faster recovery and a shorter stay.
The key treatments that improve outcome within an ERAS programme are not known.
Moreover there are few acceptable, objective endpoints to assess key outcome variables such as return of GI function.
This randomised trial will assess the potential synergy between early recovery of GI function (laxation) and early postoperative oral nutritional support(with associated preoperative preconditioning using carbohydrate/fluid loading).
The main overall outcome targets being improved recovery of gastrointestinal function, postoperative nutritional status and physical function.
It will validate the use of a novel, objective technique to measure gastric motility (surrogate for GI function).
Such refinement of ERAS should result in shorter hospital stay and better use of limited health care resource.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Anticipated)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Maastricht, Netherlands
- University Hospital Maastricht
-
-
-
-
-
Edinburgh, United Kingdom, EH16 4SA
- Edinburgh Royal Infirmary
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing hepatic resection for benign or malignant conditions
- Able to understand the nature of the study and what will be required of them.
- Men and non-pregnant, non-lactating women
- BMI 18 - 30
Exclusion Criteria:
- Inability to give written, informed consent
- Patients with dementia or neurological impairment
- Patients with pre-existing condition limiting mobility
- Planned bile duct excision
- Repeat or staged procedures
- Central extended resections
- Underlying cirrhotic liver disease
- Jaundice (Bilirubin > 50 μmol/L)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: 1
Follow a standard Enhanced Recovery After Surgery protocol
|
|
EXPERIMENTAL: 2
Follow a standard Enhanced Recovery After Surgery protocol and will receive 1 g of Magnesium Oxide laxative twice daily from the day after surgery until discharge
|
20 ml of Magnesium Oxide twice daily from the day after surgery until discharge
|
EXPERIMENTAL: 3
Follow a standard Enhanced Recovery After Surgery protocol and will receive preconditioning with carbohydrate and fluid loading prior to surgery (800ml of Nutricia Preop the evening before surgery and 400 the morning of surgery 2 hours prior to anaesthesia) and postoperative nutritional supplements (200 ml Nutricia Fortisip twice daily) after surgery for 30 days
|
Nutricia PreOP drinks 800 ml between 8-10 pm the evening before surgery Nutricia PreOP drinks 400 ml completed 2 hours before anaesthesia on the morning of surgery Nutricia Fortisip drinks 2 x 200 ml drinks from the day after surgery until day 30
|
EXPERIMENTAL: 4
Follow a standard Enhanced Recovery After Surgery protocol and will receive preconditioning with carbohydrate and fluid loading prior to surgery (800ml of Nutricia Preop the evening before surgery and 400 the morning of surgery 2 hours prior to anaesthesia) and postoperative nutritional supplements (200 ml Nutricia Fortisip twice daily) after surgery for 30 days and will receive postoperative laxative in the form of 20 ml of Magnesium Oxide twice daily form the day after surgery until discharge
|
20 ml of Magnesium Oxide twice daily from the day after surgery until discharge
Nutricia PreOP drinks 800 ml between 8-10 pm the evening before surgery Nutricia PreOP drinks 400 ml completed 2 hours before anaesthesia on the morning of surgery Nutricia Fortisip drinks 2 x 200 ml drinks from the day after surgery until day 30
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Recovery of gastrointestinal function: Time to pass flatus/stool (hours following the end of surgery)
Time Frame: Number of hours post surgery
|
Number of hours post surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
t ½ Gastric emptying time on the morning of post-operative day 3
Time Frame: Postoperative day 3
|
Postoperative day 3
|
Length of hospital stay: nights spent in hospital post-op
Time Frame: Until discharge
|
Until discharge
|
Patient activity level: measured by activPAL® activity meter
Time Frame: postoperative day 2 - 7 and day 30 - 37
|
postoperative day 2 - 7 and day 30 - 37
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Paul Hendry, MBChB, University of Edinburgh
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2006
Study Completion (ACTUAL)
August 1, 2008
Study Registration Dates
First Submitted
October 2, 2007
First Submitted That Met QC Criteria
October 2, 2007
First Posted (ESTIMATE)
October 3, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
November 5, 2010
Last Update Submitted That Met QC Criteria
November 4, 2010
Last Verified
October 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UEdinburgh
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Liver Metastases
-
Humanitas Clinical and Research CenterCompletedColorectal Cancer | Liver Metastases | Immunotherapy | Colorectal Liver Metastases
-
Mayo ClinicRecruitingColorectal Cancer | Colorectal Liver MetastasesUnited States
-
Shanghai Changzheng HospitalNot yet recruiting
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Completed
-
Fudan UniversityNot yet recruitingColorectal Cancer Liver MetastasesChina
-
Vastra Gotaland RegionRecruitingColorectal Cancer | Liver Metastases | Colorectal Liver MetastasesSweden
-
Fudan UniversityUnknown
-
University of ZurichCompletedColorectal Liver MetastasesSwitzerland, France, Spain
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Liver Metastases | RegorafenibChina
-
Ye XuUnknownResected Liver Metastases From Colorectal CancerChina
Clinical Trials on Standard ERAS group
-
JIANG Zhi-WeiCompleted
-
Johns Hopkins UniversityRecruiting
-
Vanderbilt University Medical CenterEdwards LifesciencesCompletedColorectal Surgery | Perioperative Care | Quality Improvement | ERASUnited States
-
GEM Hospital & Research CenterCompleted
-
Erasca, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States
-
Hospital General Universitario ElcheUnknown
-
First Affiliated Hospital of Chongqing Medical...Enrolling by invitation
-
West China HospitalRecruitingArthroplasty, Replacement, Hip, KneeChina
-
The First Hospital of Jilin UniversityCompleted
-
University of ThessalyRecruiting